Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Molecular Partners Ag (MOLN) EBT Margin (2021 - 2025)

Historic EBT Margin for Molecular Partners Ag (MOLN) over the last 5 years, with Q3 2025 value amounting to 168555828.11%.

  • Molecular Partners Ag's EBT Margin fell 1685541632100.0% to 168555828.11% in Q3 2025 from the same period last year, while for Sep 2025 it was 263372.74%, marking a year-over-year decrease of 2623443200.0%. This contributed to the annual value of 1080.82% for FY2024, which is 8854846334700.0% up from last year.
  • Per Molecular Partners Ag's latest filing, its EBT Margin stood at 168555828.11% for Q3 2025, which was down 1685541632100.0% from 1286.17% recorded in Q1 2025.
  • In the past 5 years, Molecular Partners Ag's EBT Margin ranged from a high of 486415.0% in Q4 2021 and a low of 168555828.11% during Q3 2025
  • Its 5-year average for EBT Margin is 9337135.43%, with a median of 501.47% in 2022.
  • In the last 5 years, Molecular Partners Ag's EBT Margin skyrocketed by 137605300bps in 2023 and then plummeted by 2000000000bps in 2025.
  • Over the past 5 years, Molecular Partners Ag's EBT Margin (Quarter) stood at 486415.0% in 2021, then crashed by -100bps to 62.15% in 2022, then surged by 22140bps to 13822.69% in 2023, then tumbled by -99bps to 144.66% in 2024, then crashed by -116516080bps to 168555828.11% in 2025.
  • Its last three reported values are 168555828.11% in Q3 2025, 1286.17% for Q1 2025, and 144.66% during Q4 2024.